Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Biocon Biologics Bengaluru facility gets 5 USFDA observations

Biocon Foundation in collaboration with BeST Cluster, NCBS introduces BioWISE Program - to Empower Women in STEM

Ruchika Sharma10 Jun 2025 1:11 PM IST

Bengaluru: Biocon Foundation, the Corporate Social Responsibility arm of Biocon Group, in collaboration with The Bengaluru Science and...

USFDA concludes audit at Cohance Lifesciences Jaggaiahpet facility

USFDA classifies OneSource Bangalore drug-device combination facility as VAI

Ruchika Sharma10 Jun 2025 12:00 PM IST

Bangalore: OneSource Specialty Pharma Limited, a multi-modality specialty pharma pure-play CDMO, has announced that its flagship facility in...

Merck, Daiichi Sankyo Ifinatamab deruxtecan granted Breakthrough Therapy Designation by USFDA for pretreated extensive-stage small cell lung cancer

Merck RSV antibody Enflonsia gets USFDA okay for infants

Ruchika Sharma10 Jun 2025 11:06 AM IST

Rahway: Merck, known as MSD outside of the United States and Canada, has received approval from the U.S. Food and Drug Administration (FDA)...

Merck posts positive phase 3 trials results evaluating Enlicitide Decanoate in adults with Hyperlipidemia

Ruchika Sharma10 Jun 2025 9:00 AM IST

Rahway: Merck, known as MSD outside of the United States and Canada, has announced positive topline results from the first two of three...

AstraZeneca Pharma India names Praveen Rao Akkinepally as new MD, succeeding Dr Sanjeev Panchal

Ruchika Sharma9 Jun 2025 6:39 PM IST

Bangalore: AstraZeneca Pharma India has announced the appointment of Praveen Rao Akkinepally as the new Managing Director of the company,...

Illegal drugs manufacturing unit busted in Haridwar

Ruchika Sharma9 Jun 2025 4:35 PM IST

New Delhi: In a significant crackdown on illegal drug operations, the Narcotics Control Bureau (NCB) has uncovered an illicit drug-manufacturing unit...

Sanofi successfully prices euro 1.5 billion bond issue

Sanofi-Regeneron Dupixent data reinforce use in atopic dermatitis patients with skin of color

Ruchika Sharma9 Jun 2025 1:12 PM IST

Paris: Sanofi has announced that results from the DISCOVER phase 4, single-arm, open-label study assessing Dupixent (dupilumab) in adults and...

Bayer Gadoquatrane new drug application accepted for review by USFDA

Simultaneous treatment start with Finerenone and SGLT-2-inhibitor demonstrated positive data in patients with CKD associated with type 2 diabetes: Bayer

Ruchika Sharma9 Jun 2025 10:00 AM IST

Berlin: Bayer has announced results of the Phase II CONFIDENCE study, demonstrating that simultaneous initiation of finerenone (Kerendia)...

Banned medicated soap found in Karimnagar medical shop raid

Ruchika Sharma8 Jun 2025 4:15 PM IST

Telangana: Drugs Control Administration, Telangana, has seized a banned drug, 'Medicated Skin Care Soap containing Permethrin IP 1.0%, Cetrimide IP...

Sanofi gets USFDA fast track designation for neovascular age-related macular degeneration gene therapy

Sanofi launches 2025 Global Employee Stock Purchase Plan

Ruchika Sharma8 Jun 2025 12:30 PM IST

Paris: Sanofi's global employee shareholder plan, Action 2025, opens on June 10, 2025, to around 70,000 employees in 55 countries.In 2024 alone,...

Bayer arm secures exclusive worldwide rights to develop, commercialize clinical-stage WRN Inhibitor

Ruchika Sharma8 Jun 2025 10:00 AM IST

San Diego: Vividion Therapeutics, Inc., a clinical-stage biopharmaceutical company, and a wholly owned and independently operated subsidiary of...

Lupin Gets Expert Committee Nod To Conduct Phase I Trial of Certolizumab Pegol, IGRA TB Test Made Mandatory

Lupin bags tentative nod from USFDA for partial-onset seizures drug Oxcarbazepine ER

Ruchika Sharma7 Jun 2025 5:24 PM IST

Mumbai: Lupin Limited has announced that it has received tentative approval from the United States Food and Drug Administration (U.S. FDA) for...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok